Joint Formulary & PAD

Lisinopril / Hydrochlorothiazide - Hypertension

You are here : Home > Formulary Search > Lisinopril / Hydrochlorothiazide - Hypertension

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
NICE
SPC
Restrictions / Comments :
Important
MHRA alert: Hydrochlorothiazide risk of non-melanoma skin cancer

Documentation

Webpage
NICE NG136 - Hypertension in adults: diagnosis and management

PAD Profile

ChemicalSubstance :
Lisinopril / Hydrochlorothiazide
Indication :
Hypertension
Group Name :
Keywords :
Brand Names Include :
Zestoretic
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Hypertension
Supporting Documents :
1

Committee Recommendations (1)

03 May 17 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
GENERIC lisinopril / hydrochlorothiazide has been considered by the PCN and has been assigned a GREEN traffic light status.

NOTE - the branded product, Zestoretic, was considered BLACK at the PCN in May 2017.

Other Indications

Below are listed other indications that Lisinopril / Hydrochlorothiazide is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Hypertension.